Search For "booster dose"
CoviVac suitable as booster dose for people who received other vaccines: D
Updated : 7 months, 2 weeks ago IST
Moscow [Russia], November 18 (ANI/Sputnik): The Russian CoviVac vaccine against COVID-19 is suitable as a booster dose for people who initially received other vaccines, Aydar Ishmukhametov, the head of the Chumakov research center, said on Thursday.
Read More
COVID vaccine booster dose should be given to people with comorbidities: E
Updated : 7 months, 3 weeks ago IST
New Delhi [India], November 11 (ANI): COVID vaccine booster dose should be given to people with comorbidities, said an expert.
Read More
Booster dose of COVID-19 vaccine required if virus gets mutated, says Bhar
Updated : 7 months, 3 weeks ago IST
New Delhi [India], November 11 (ANI): People will need booster doses of the COVID-19 vaccine if the COVID-19 virus gets mutated, said Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella.
Read More
Booster dose of COVID-19 vaccine 95.6 pc effective, say Pfizer, BioNTech
Updated : 8 months, 2 weeks ago IST
Washington [US], October 21 (ANI): Pfizer and BioNTech said on Thursday that a booster shot of their COVID-19 vaccine has shown 95.6 per cent efficacy when compared to those who did not receive the booster dose.
Read More
FDA takes additional actions on use of booster dose for COVID-19 vaccines
Updated : 8 months, 2 weeks ago IST
Washington [US], October 21 (ANI): The US Food and Drug Administration (FDA) approved the use of third doses of the Moderna and Johnson and Johnson (Janssen) vaccines against the novel COVID-19 for eligible individuals.
Read More
WHO panel to discuss need for COVID-19 booster shots on November 11
Updated : 8 months, 4 weeks ago IST
Geneva [Switzerland], October 12 (ANI): A advisory panel of the World Health Organization (WHO) is set to discuss the need for COVID-19 booster doses on November 11.
Read More
Talks of booster Covid vaccine dose in India not pertinent at present, say
Updated : 9 months, 1 week ago IST
New Delhi [India], September 30 (ANI): Underlining that more than 95 per cent of the antibodies persist for over a year among COVID-19 vaccinated persons as per some studies, the Union Health Ministry on Thursday cleared the air on booster dose, saying talks in this regard are not pertinent
Read More
Focus is to fully vaccinate adult population, booster dose not pertinent a
Updated : 9 months, 1 week ago IST
New Delhi [India], September 30 (ANI): Indian Council of Medical Research Director-General Balram Bhargava on Thursday said that the main focus is to fully vaccinate the adult population of the country, adding that the issue of booster dose is not pertinent at the moment.
Read More
US CDC panel endorses Pfizer booster shot for elderly, high-risk people
Updated : 9 months, 2 weeks ago IST
Washington [US], September 24 (ANI/Xinhua): A U.S. Centers for Disease Control and Prevention (CDC) advisory panel on Thursday endorsed booster doses of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with certain high risk conditions.
Read More
Focus should be on vaccinating everybody, booster doses can wait: AIIMS ch
Updated : 10 months, 2 weeks ago IST
New Delhi [India], August 25 (ANI): India should now focus on vaccinating as many people as possible to curb the spread of Covid and the idea of booster doses can wait, for now, said Randeep Guleria, Chief, All India Institute Of Medical Sciences (AIIMS).
Read More
No data shows need for booster vaccines presently: Dr Gagandeep Kang
Updated : 10 months, 3 weeks ago IST
New Delhi [India], August 17 (ANI): Speaking about when a booster dose should be administered, Dr Gagandeep Kang, professor at Christian Medical College Vellore on Tuesday, said some countries that have used inactivated, vectored vaccines or mRNA vaccines have begun to offer a booster dose t
Read More
Pfizer and BioNTech announce submission of Initial data to US FDA to suppo
Updated : 10 months, 3 weeks ago IST
New York [US], August 17 (ANI): Pfizer and BioNTech announced that they have submitted Phase 1 data to the United States Food and Drug Administration (FDA) to support the evaluation of a third, or booster dose of the companies' COVID-19 vaccine for future licensure.
Read More
